New research suggests that patients who come off popular weight-loss injections like Wegovy and Mounjaro may regain reduced body mass at a significantly accelerated pace than those who halt conventional lifestyle regimens.
Published data in a prominent medical journal demonstrates that while obese people often shed substantial amounts of their body weight while on the medication, the weight comes back at an estimated rate of 0.8 kg per month after stopping.
"People buying such medications must be aware of the risk of fast weight regain when the treatment is stopped," warns researcher Dr. Susan Jebb.
That rate of regain suggests a return to pre-treatment weight within about 18 months.
Comparing Therapies
The study, which reviewed dozens of studies involving over 9,000 of patients, contrasted the results of these new drugs with older methods.
Researchers note that people who lose weight through lifestyle changes alone typically have a more gradual creep back—around 100 grams monthly—post-intervention.
Understanding the Quick Rebound
Nutrition scientists believe the way of the jabs is key to understanding the accelerated weight return.
These medications copy a body's own chemical called GLP-1, which moderates appetite.
"Artificially providing GLP-1 levels far above than normal may cause the system to produce less of its own natural hormone, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this hormone supplement means hunger is uncontrolled, making overeating far more likely."
A Chronic Condition?
Medical guidelines advise the injections for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.
A number of clinicians argue that, considering the significant potential of weight regain, the treatment is often ongoing.
This view is reinforced by pharmaceutical companies, who say that the findings "emphasize the long-term nature of obesity," similar to managing conditions like diabetes.
User Accounts
Users who have discontinued the jabs explain a intense return of hunger.
"It was like something flipping and I was suddenly starving," recalled a patient.
This difficulty is worsened if patients have not developed lasting lifestyle or habit changes during therapy.
Widespread Interest
Recent estimates suggest that a significant number of people in the UK have tried weight-loss jabs in the past year, with demand remaining high.
- Adoption is higher among females compared to males.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion obtain the drugs through private healthcare rather than public health services.
In conclusion, experts stress that while these medications are powerful agents for shedding pounds, they are not a standalone solution and long-term success likely depends on combined lifestyle support.
